BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 17, 2026
Breaking News: Tracking hantavirus across the globeBreaking News: Tracking hantavirus across the globeBreaking News: Tracking hantavirus across the globe
Home » Topics » BioWorld Science

BioWorld Science
BioWorld Science RSS Feed RSS

Cancer

Nido Biosciences divulges new SARMs

Feb. 10, 2023
Nido Biosciences Inc. has synthesized bicyclic compounds acting as selective androgen receptor modulators (SARMs) reported to be useful for the treatment of spinal and bulbar muscular atrophy, neurodegeneration and cancer.
Read More
Neurology/Psychiatric

Sichuan Haisco Pharmaceutical patents AAK1 inhibitors for diabetic neuropathy and postherpetic neuralgia

Feb. 10, 2023
Sichuan Haisco Pharmaceutical Co. Ltd. has disclosed AP2-associated protein kinase 1 (AAK1) inhibitors reported to be useful for the treatment of diabetic neuropathy and postherpetic neuralgia.
Read More
Illustration of neuron, synapse.
Neurology/Psychiatric

Synapse organizers LRRTM1 and SynCAM 1 have concerted roles in the prefrontal cortex of mice

Feb. 10, 2023
Trans-synaptic complexes regulate synapse development and maturation. Disorders involving synaptopathies, such as schizophrenia, affect specific regions of the brain.
Read More
Illustration of blood vessel that isn't clotting due to hemophilia
Biomarkers

Osteoprotegerin as a biomarker of hemophilia

Feb. 10, 2023

Previous research has suggested that factor VIII (FVIII) can regulate the osteoprotegerin (OPG)/RANKL system, which appears to play a role in hemophilic arthropathy. Investigators have now aimed to measure the OPG levels in patients with hemophilia A/B and assess their correlation with the levels of FVIII/FIX.


Read More
Pancreas
Cancer

NIH grant supports partnership to study TGX-1214 with immune checkpoint inhibition for PDAC

Feb. 10, 2023
UC Davis Comprehensive Cancer Center is partnering with Targagenix Inc. and Northeastern University to study pancreatic ductal adenocarcinoma (PDAC). The partnership will receive nearly US$3 million over 5 years through funding from the National Institutes of Health (NIH).
Read More
Red blood cells illustration.
Biomarkers

New ITGA2B gene compound heterozygous mutation found in Glanzmann thrombasthenia

Feb. 10, 2023
Glanzmann thrombasthenia (GT) is a rare bleeding disorder caused by defects in the expression of platelet surface integrins, such as integrin alpha-IIb (GPIIb, encoded by ITGA2B).
Read More
Cross-section of brain
Neurology/Psychiatric

circSCMH1 promotes vascular repair after stroke through FTO-regulated methylation

Feb. 10, 2023
Circular RNAs (circRNAs) are non-coding RNAs abundant in the brain, and several of them are functionally involved in ischemic stroke.
Read More
Gastrointestinal

MaR2 thermostable nanoparticles promote mucosal repair in inflammatory disease

Feb. 10, 2023
Maresin-2 (MaR2) is a bioactive lipid derived from omega-3 polyunsaturated fatty acid.
Read More
Tree in the shape of human head losing leaves
Neurology/Psychiatric

Much remains mysterious about cognitive decline

Feb. 10, 2023
By Anette Breindl
The shunt towards, or away from, cognitive decline may happen decades before such decline becomes clinically evident. And known risk factors explain very little of that decline. That is the conclusion reached by researchers from the Ohio State University, who published their results in the Feb. 8, 2023, issue of PLOS ONE.

In their analysis, the team looked at both the absolute level of cognitive function in about 7,000 participants of the U.S. Health and Retirement Study at age 54, and at the decline in cognitive function from age 54 to 85. The study participants that were analyzed were born between 1931 and 1941. The results were reminiscent of the adage that the way to make a silk purse out a sow’s ear is to start with a silk sow.
Read More

Other news to note for Feb. 9, 2023

Feb. 9, 2023
Additional early-stage research and drug discovery news in brief, from: Enzolytics, Evaxion Biotech, Hoth Therapeutics, Lineage Cell Therapeutics, Lixte Biotechnology Holdings, Pantherna Therapeutics.
Read More
Previous 1 2 … 1186 1187 1188 1189 1190 1191 1192 1193 1194 … 18070 18071 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Amyloid plaques on nerve cell

    Roche secures CE mark for Alzheimer’s blood test

    BioWorld
    Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing